长春高新：支付丹麦过敏药的首付款在三季度报表中未包括，相关合作是9月中下旬达成的

Group 1 - The company received a question from investors regarding the visibility of the upfront payment for a Danish allergy medication in the Q3 financial report [2] - The company clarified that the relevant collaboration was only established in mid to late September and therefore is not included in the current financial statements [2]